---
title: "Shanghai Lingang has been approved to issue corporate bonds not exceeding 6 billion yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239304858.md"
description: "According to the Zhitong Finance APP, Shanghai Lingang announced that the company recently received the \"Approval on the Registration of Shanghai Lingang Holdings Co., Ltd. to Publicly Issue Corporate Bonds to Professional Investors\" issued by the China Securities Regulatory Commission (CSRC) (Zheng Jian Xu Ke [2025] No. 955). The approval content is as follows: 1. The company is authorized to publicly issue corporate bonds with a total face value not exceeding 6 billion yuan to professional investors"
datetime: "2025-05-08T09:50:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239304858.md)
  - [en](https://longbridge.com/en/news/239304858.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239304858.md)
generator: "portal-rs"
---

# Shanghai Lingang has been approved to issue corporate bonds not exceeding 6 billion yuan

According to the Zhitong Finance APP, Shanghai Lingang (600848.SH) announced that it recently received the "Approval from the China Securities Regulatory Commission for Shanghai Lingang Holdings Co., Ltd. to publicly issue corporate bonds to professional investors" (CSRC Permit \[2025\] No. 955). The approval content is as follows: 1. The company is allowed to publicly issue corporate bonds with a total face value not exceeding 6 billion yuan to professional investors

### Related Stocks

- [900928.CN](https://longbridge.com/en/quote/900928.CN.md)
- [600848.CN](https://longbridge.com/en/quote/600848.CN.md)

## Related News & Research

- [Money Managers Turn Bullish On China Despite Mounting Economic Woes](https://longbridge.com/en/news/296554795.md)
- [Stocks in Play: Metro Inc.](https://longbridge.com/en/news/296508762.md)
- [Shein pushes back Hong Kong debut to September amid delayed orders: sources](https://longbridge.com/en/news/296473290.md)
- [08:12 ETAXIS-Y Expands GCC Presence with Landmark Kuwait and Bahrain Launch](https://longbridge.com/en/news/296616640.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**